1. Home
  2. ABR vs KYMR Comparison

ABR vs KYMR Comparison

Compare ABR & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABR
  • KYMR
  • Stock Information
  • Founded
  • ABR 2003
  • KYMR 2015
  • Country
  • ABR United States
  • KYMR United States
  • Employees
  • ABR N/A
  • KYMR N/A
  • Industry
  • ABR Real Estate Investment Trusts
  • KYMR Medicinal Chemicals and Botanical Products
  • Sector
  • ABR Real Estate
  • KYMR Health Care
  • Exchange
  • ABR Nasdaq
  • KYMR Nasdaq
  • Market Cap
  • ABR 2.6B
  • KYMR 2.7B
  • IPO Year
  • ABR 2004
  • KYMR 2020
  • Fundamental
  • Price
  • ABR $12.00
  • KYMR $36.81
  • Analyst Decision
  • ABR Hold
  • KYMR Buy
  • Analyst Count
  • ABR 6
  • KYMR 15
  • Target Price
  • ABR $14.00
  • KYMR $55.27
  • AVG Volume (30 Days)
  • ABR 3.4M
  • KYMR 456.1K
  • Earning Date
  • ABR 02-21-2025
  • KYMR 02-27-2025
  • Dividend Yield
  • ABR 14.33%
  • KYMR N/A
  • EPS Growth
  • ABR N/A
  • KYMR N/A
  • EPS
  • ABR 1.18
  • KYMR N/A
  • Revenue
  • ABR $553,580,000.00
  • KYMR $87,563,000.00
  • Revenue This Year
  • ABR N/A
  • KYMR N/A
  • Revenue Next Year
  • ABR N/A
  • KYMR $32.89
  • P/E Ratio
  • ABR $10.17
  • KYMR N/A
  • Revenue Growth
  • ABR N/A
  • KYMR 86.92
  • 52 Week Low
  • ABR $11.87
  • KYMR $29.24
  • 52 Week High
  • ABR $15.94
  • KYMR $53.27
  • Technical
  • Relative Strength Index (RSI)
  • ABR 22.95
  • KYMR 42.51
  • Support Level
  • ABR $13.61
  • KYMR $36.67
  • Resistance Level
  • ABR $13.91
  • KYMR $38.24
  • Average True Range (ATR)
  • ABR 0.42
  • KYMR 1.78
  • MACD
  • ABR -0.08
  • KYMR 0.06
  • Stochastic Oscillator
  • ABR 5.19
  • KYMR 51.81

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.

Share on Social Networks: